DDX27 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.179000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.813200E-01
Normal-vs-Stage2
5.629600E-01
Normal-vs-Stage3
4.192000E-01
Normal-vs-Stage4
3.372400E-01
Stage1-vs-Stage2
2.208000E-01
Stage1-vs-Stage3
3.896200E-01
Stage1-vs-Stage4
7.791600E-02
Stage2-vs-Stage3
7.896000E-02
Stage2-vs-Stage4
6.312600E-01
Stage3-vs-Stage4
9.331700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.153800E-01
Normal-vs-AfricanAmerican
5.350000E-01
Normal-vs-Asian
9.188000E-01
Caucasian-vs-AfricanAmerican
6.890800E-01
Caucasian-vs-Asian
4.245800E-01
AfricanAmerican-vs-Asian
3.470400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.387800E-01
Normal-vs-Female
7.388800E-01
Male-vs-Female
2.118200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.519400E-01
Normal-vs-Age(41-60Yrs)
3.313600E-01
Normal-vs-Age(61-80Yrs)
7.983000E-01
Normal-vs-Age(81-100Yrs)
5.702000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.691600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.175200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.052600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.243800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.984600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.113800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.065000E-01
Normal-vs-Daily Drinker
5.851000E-01
Normal-vs-Weekly Drinker
6.384000E-01
Normal-vs-Occasional Drinker
2.182600E-01
Normal-vs-Social Drinker
6.604600E-01
Non Drinker-vs-Daily Drinker
2.575800E-01
Non Drinker-vs-Weekly Drinker
5.079600E-01
Non Drinker-vs-Occasional Drinker
5.454100E-02
Non Drinker-vs-Social Drinker
6.786800E-01
Daily Drinker-vs-Weekly Drinker
6.992800E-01
Daily Drinker-vs-Occasional Drinker
6.259400E-01
Daily Drinker-vs-Social Drinker
4.499200E-01
Weekly Drinker-vs-Occasional Drinker
2.921800E-01
Weekly Drinker-vs-Social Drinker
7.591400E-01
Occasional Drinker-vs-Social Drinker
1.070780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.941200E-01
Normal-vs-Grade 2
9.860200E-01
Normal-vs-Grade 3
9.421000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.186000E-02
Grade 1-vs-Grade 3
4.860200E-03
Grade 1-vs-Grade 4
8.941200E-01
Grade 2-vs-Grade 3
9.096300E-02
Grade 2-vs-Grade 4
9.860200E-01
Grade 3-vs-Grade 4
9.421000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.987400E-01
Normal-vs-NonDiabetic
5.535400E-01
Diabetic-vs-NonDiabetic
2.759400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.497200E-01
Normal-vs-NoPancreatitis
6.656400E-01
Pancreatitis-vs-NoPancreatitis
2.302200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.873200E-01
Normal-vs-N1
5.843400E-01
N0-vs-N1
2.522000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.134400E-01
Normal-vs-TP53-NonMutant
8.657800E-01
TP53-Mutant-vs-TP53-NonMutant
5.13779999988806E-07
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
